All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AZURRX BIOPHARMA, INC. Last Reported: 12/31/2020 Stock Symbol: AZRX

Business Address

1615 SOUTH CONGRESS AVENUE
SUITE 103
DELRAY BEACH, FL US 33445

Mailing Address

1615 SOUTH CONGRESS AVENUE
SUITE 103
DELRAY BEACH, FL US 33445
Phone Number: 646-699-7855 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 9/30/2015 12/31/2014
Cash and Cash Equivalents -- $11,368,680.00 $984,950.00 $1,630,007.00 $175,796.00 $1,549,825.00 $1,310,687.00 $413,858.00 $1,114,343.00 $4,427,640.00 $7,420,425.00 $574,474.00 $573,471.00 -- -- -- -- -- -- -- -- -- --
Accounts Receivable Net Current $551,489.00 $20,688.00 $102,601.00 $760,232.00 $2,637,303.00 $2,090,233.00 $2,119,700.00 $2,051,028.00 $3,172,676.00 $1,197,196.00 $1,081,378.00 $1,015,345.00 $1,104,134.00 $173,589.00 $978,738.00 $1,010,963.00 $961,038.00 $250,529.00 -- -- $1,074,858.00 -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Assets $7,869,784.00 $11,537,972.00 $1,600,921.00 $2,897,436.00 $3,408,286.00 $3,729,814.00 $3,628,632.00 $2,803,542.00 $4,800,001.00 $5,683,293.00 $8,634,127.00 $1,805,945.00 $1,952,568.00 $3,184,825.00 $5,030,615.00 $1,750,056.00 $2,963,974.00 $1,361,408.00 -- -- $2,067,360.00 -- --
Property Plant and Equipement $18,329.00 $54,070.00 $62,054.00 $73,547.00 $77,391.00 $95,367.00 $108,187.00 $125,135.00 $128,854.00 $136,963.00 $145,024.00 $148,777.00 $133,987.00 $147,677.00 $150,213.00 $141,358.00 $151,622.00 $163,660.00 -- -- $176,319.00 -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill $2,054,048.00 $1,968,519.00 $1,889,879.00 $1,844,006.00 $1,886,686.00 $1,832,915.00 $1,913,740.00 $1,887,358.00 $1,924,830.00 $1,952,724.00 $1,966,670.00 $2,071,356.00 $2,016,240.00 $1,973,056.00 $1,917,436.00 $1,797,292.00 $1,767,550.00 $1,888,367.00 -- -- $1,832,579.00 -- $2,042,454.00
Other Assets -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $12,923,855.00 $16,722,021.00 $6,861,788.00 $8,184,312.00 $8,902,880.00 $9,435,723.00 $9,612,406.00 $8,956,510.00 $7,469,395.00 $8,578,368.00 $11,739,238.00 $5,247,946.00 $5,479,668.00 $6,836,368.00 $8,764,296.00 $5,423,740.00 $6,753,842.00 $5,585,765.00 -- -- $6,685,682.00 -- --
Accounts Payable $1,685,603.00 $1,686,003.00 $1,314,281.00 $1,039,219.00 $1,754,682.00 $2,754,217.00 $3,041,167.00 $2,580,709.00 $2,070,396.00 $826,410.00 $1,259,889.00 $1,797,221.00 $1,187,234.00 $1,533,451.00 $1,023,497.00 $1,696,747.00 $1,471,280.00 $1,760,897.00 -- -- $781,985.00 -- --
Accrued Liabilities $127,012.00 $263,937.00 $113,935.00 $119,935.00 $71,177.00 $509,597.00 $758,230.00 $69,930.00 $285,061.00 $164,400.00 $302,430.00 $290,810.00 $262,200.00 -- -- $98,750.00 $73,750.00 $29,590.00 -- -- $174,210.00 -- --
Total Current Liabilities $15,564,548.00 $2,656,783.00 $7,659,238.00 $5,143,189.00 $4,285,636.00 $6,233,949.00 $6,664,304.00 $6,243,185.00 $2,995,523.00 $3,046,045.00 $4,110,911.00 $4,149,450.00 $3,819,076.00 $4,040,914.00 $4,119,706.00 $3,952,725.00 $3,540,840.00 $17,951,676.00 -- -- $10,315,512.00 -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $-1,112,546.00 $-1,211,548.00 $-1,272,780.00 $-1,109,061.00 $-1,266,555.00 $-1,357,146.00 $-1,218,905.00 $-1,245,393.00 $-1,150,112.00 $-1,095,823.00 $-1,059,608.00 $-849,695.00 $-955,715.00 $-1,022,576.00 $-1,170,019.00 $-1,400,189.00 $-1,461,875.00 $-1,213,774.00 -- -- $-1,346,064.00 -- --
Accumulated Deficit $-95,366,198.00 $-77,965,806.00 $-72,651,900.00 $-67,956,022.00 $-62,694,732.00 $-61,413,109.00 $-57,220,637.00 $-52,177,801.00 $-47,517,046.00 $-43,497,239.00 $-40,925,603.00 $-37,616,426.00 $-33,983,429.00 $-31,502,418.00 $-28,368,195.00 $-25,696,412.00 $-22,887,046.00 $-17,255,522.00 -- -- $-8,295,384.00 -- --
Total Stockholders' Equity $-2,640,693.00 $14,065,238.00 $-797,450.00 $3,041,123.00 $4,617,244.00 $3,201,774.00 $2,948,102.00 $2,713,325.00 $4,473,872.00 $5,532,323.00 $7,628,327.00 $1,098,496.00 $1,660,592.00 $2,795,454.00 $4,644,590.00 $1,471,015.00 $3,213,002.00 $-12,365,911.00 $-9,234,602.00 $-5,419,507.00 $-3,629,830.00 $-2,793,092.00 $2,644,898.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $12,923,855.00 $16,722,021.00 $6,861,788.00 $8,184,312.00 $8,902,880.00 $9,435,723.00 $9,612,406.00 $8,956,510.00 $7,469,395.00 $8,578,368.00 $11,739,238.00 $5,247,946.00 $5,479,668.00 $6,836,368.00 $8,764,296.00 $5,423,740.00 $6,753,842.00 $5,585,765.00 -- -- $6,685,682.00 -- --

Statement of Operations

Date 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 9/30/2015 12/31/2014
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $5,888,004.00 $4,438,229.00 $1,089,177.00 $1,553,360.00 $8,680,669.00 $2,210,091.00 $4,857,301.00 $2,118,533.00 $4,985,553.00 $3,772,679.00 $2,603,805.00 $1,678,029.00 $2,395,478.00 $966,685.00 $1,277,559.00 $534,137.00 $2,496,105.00 $744,309.00 $840,662.00 $685,575.00 $1,398,056.00 $1,734,484.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $26,432,768.00 -- -- -- $14,743,747.00 -- -- -- $13,431,771.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-26,432,768.00 $-3,711,934.00 $-2,393,704.00 $-2,928,451.00 $-14,743,747.00 $-13,617,908.00 $-9,535,834.00 $-4,603,644.00 $-13,431,771.00 $-9,413,391.00 $-3,263,023.00 $-3,584,362.00 $-10,221,184.00 $-7,919,044.00 $-2,384,435.00 $-2,808,492.00 $-6,325,158.00 $-2,188,030.00 $-1,724,972.00 $-1,347,216.00 $-4,728,808.00 $-1,408,964.00 --
Loss Before Income Taxes $-32,671,466.00 $-15,271,074.00 $-4,695,878.00 $-5,261,290.00 $-15,177,686.00 $-13,896,063.00 $-5,042,837.00 $-4,660,755.00 -- $-9,513,809.00 $-3,309,177.00 $-3,632,997.00 $-11,096,383.00 $-8,615,371.00 $-2,671,782.00 $-2,809,366.00 $-14,591,662.00 $-8,960,139.00 $-3,770,651.00 $-1,991,320.00 $-5,930,236.00 $-5,264,028.00 --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 150,000,000 150,000,000 150,000,000 100,000,000 150,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 100,000,000 -- -- 100,000,000 -- --
Common Stock Shares Outstanding 31,150,309 28,881,984 28,502,850 27,157,651 26,800,519 26,155,111 21,103,434 18,537,958 17,704,925 16,940,462 16,792,395 12,602,395 12,042,574 11,421,702 11,118,160 9,631,088 9,631,088 6,028,928 -- -- 4,296,979 -- --
Common Stock Value $3,115.00 $2,888.00 $2,850.00 $2,716.00 $2,680.00 $2,615.00 $2,110.00 $1,853.00 $1,771.00 $1,694.00 $1,679.00 $1,260.00 $1,205.00 $1,142.00 $1,112.00 $963.00 $963.00 $603.00 -- -- $430.00 -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 5,195 5,195 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- 10,000,000 -- --
Preferred Stock Shares Outstanding -- 2,878 -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- 71 -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- $3,479,000.00 -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2021 PursePoor.com